Danaher (DHR) Divestments (2010 - 2023)

Danaher (DHR) posted Divestments of -$14.0 million for Q3 2023, down 40.0% on a QoQ basis from -$10.0 million in Q2 2023.

Analysis

Danaher (DHR) Divestments (2010 - 2023) Analysis & Trends

Danaher has reported Divestments for 10 years, with the latest figure at -$14.0 million in Q3 2023.

On a quarterly basis, Divestments changed N/A year-over-year to -$14.0 million in Q3 2023; TTM through Jun 2024 was -$14.0 million, a 26.32% increase from a year earlier, with the FY2023 full-year figure at -$33.0 million, up 62.92% from the prior year.
Divestments was -$14.0 million for Q3 2023 at Danaher, down from -$10.0 million in the prior quarter.
The five-year high for Divestments was -$9.0 million in Q1 2023, with the low at -$26.6 million in Q2 2019.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Divestments (Qtr)
1	Thermo Fisher Scientific	241.68 Bn	237.61 Bn	8.34 Bn	-
2	Danaher	147.34 Bn	142.99 Bn	3.61 Bn	-
3	Agilent Technologies	43.34 Bn	41.59 Bn	1.04 Bn	-
4	Illumina	34.58 Bn	33.41 Bn	770.00 Mn	-
5	Revvity	16.31 Bn	15.29 Bn	416.87 Mn	-
6	Bio-Techne	11.28 Bn	11.01 Bn	211.39 Mn	1.42 Mn
7	Bio-Rad Laboratories	10.16 Bn	8.54 Bn	345.80 Mn	-
8	Repligen	9.77 Bn	8.75 Bn	110.04 Mn	-
9	10x Genomics	9.45 Bn	8.90 Bn	112.50 Mn	-
10	Bruker	9.26 Bn	9.04 Bn	416.00 Mn	-

Historic Data

Download Data